Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 43 Breast 13 Genitourinary 11 Myeloid 10 Plasma cell 9 Classical hematology 9 Thoracic 8 Gynecologic 8 Head & Neck 5 Tumor-Agnostic 4 Other neoplasm 3 Dermatologic 3 Sarcoma 2 Other hematologic neoplasm 2 CNS 2 Other solid neoplasm 1 Other 1 Lymphoid 1

Conditions

Interventions

Exercise 27 Metformin 24 Methods 14 Radiotherapy 13 Early Intervention, Educational 13 Educational Status 12 Counseling 12 Surveys and Questionnaires 10 Standard of Care 10 Nutrition Assessment 9 Resistance Training 8 Diet Therapy 8 Cisplatin 8 naloxegol 7 Tirzepatide 7 Diet 7 alvimopan 6 Psychiatric Rehabilitation 6 Fibroblast Growth Factor 7 6 Caloric Restriction 6 Radiation 5 Low-Level Light Therapy 5 Liraglutide 5 Injections 5 Exenatide 5 Dexamethasone 5 Cryotherapy 5 semaglutide 4 angiotensin I (1-7) 4 Vitamin D 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Aspirin × Other × Clear all

NCT02062255 2016-10-26

Impact of COX2 on Sera Biomarkers From Obese Subjects

The University of Texas Health Science Center at San Antonio

Phase EARLY_PHASE1 Completed

Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡